Uveitis, flare ups and challenges in clinical trials

In this episode of EyePod, Ora Clinical’s Keith Lane discusses uveitis and flare ups, including challenges in clinical trials.

Related Videos
Related Content

Optimizing vision outcomes and diabetic macular edema

March 30th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

International Harrington Prize jointly awarded to ophthalmologists

March 8th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Verana Health + AAO IRIS Registry joint initiative yields 3.5 million ophthalmic images

October 31st 2022

Optimizing vision outcomes and diabetic macular edema

March 30th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

International Harrington Prize jointly awarded to ophthalmologists

March 8th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Verana Health + AAO IRIS Registry joint initiative yields 3.5 million ophthalmic images

October 31st 2022

Optimizing vision outcomes and diabetic macular edema

March 30th 2023

Highlighting results from first FDA-reported study for treatment of presbyopia

September 27th 2021

International Harrington Prize jointly awarded to ophthalmologists

March 8th 2023

Integrating AI to manage DR in a primary care setting

December 1st 2020

ML6710i photodynamic laser for use with VISUDYNE approved by the FDA

February 1st 2023

Verana Health + AAO IRIS Registry joint initiative yields 3.5 million ophthalmic images

October 31st 2022
© 2023 MJH Life Sciences

All rights reserved.